Their rapid adoption underscores just how quickly the treatment paradigm has shifted
In contrast to traditional treatments for sexual dysfunction, which mainly concentrate on improving blood flow or hormone levels, Moore says, PT-141 directly tackles the underlying neurological factors contributing to low libido, providing a focused and potentially effective solution for enhancing sexual desire. That goes for both sexes who chronically experience a lack of interest in sex
Current smoking cessation guideline bodies (including the American Lung Association) continue to recommend varenicline, bupropion, and nicotine replacement therapy as evidence-based first-line treatments
Martnez de Toda I, Gonzlez-Snchez M, Daz-Del Cerro E, Valera G, Carracedo J, Guerra-Prez N
CrossRef The regulatory role of circGDI2 in hepatocellular carcinoma proliferation and glycolysis with the involvement of m6A modification Shiyi Chen, Hongxiang Xia, Shuwei Chen Non-coding RNA Research .2026
Parker, V